{{org_field_logo}}

{{org_field_name}}

Registration Number: {{org_field_registration_no}}

---

PRN Medication Management Policy

1. Purpose

The purpose of this policy is to ensure the safe, effective, and appropriate management of PRN (Pro Re Nata, or “as required”) medication within {{org_field_name}}. PRN medication is used to manage symptoms such as pain, anxiety, agitation, and other conditions when needed. This policy ensures compliance with the Regulation and Inspection of Social Care (Wales) Act 2016, CIW regulations, the Social Services and Well-being (Wales) Act 2014, and best practices in medication management.

2. Scope

This policy applies to all staff involved in administering, recording, reviewing, and auditing PRN medication within {{org_field_name}}, including care staff, nurses, and management. It ensures that PRN medication is administered only when clinically justified, with appropriate documentation and oversight.

3. Principles of PRN Medication Management

{{org_field_name}} is committed to the following key principles:

• Safe Administration: PRN medication is given in line with prescribing instructions and only when necessary.
• Person-Centred Approach: Medication is administered with respect for the individual’s preferences and assessed needs.
• Regular Review: PRN medication use is regularly reviewed to ensure effectiveness and prevent overuse.
• Clear Documentation: All administrations, refusals, and effects of PRN medication are clearly recorded.
• Staff Training: All staff involved in PRN medication management receive appropriate training.

4. Assessment and Decision-Making for PRN Medication

• Prescriber’s Instructions:
  • PRN medication must be prescribed by a healthcare professional with clear dosage, indications, and maximum daily limits.
• Identifying Need:
  • Staff assess the resident’s symptoms before administering PRN medication.
  • Non-pharmacological interventions should be considered before PRN medication is given.
• Resident Involvement:
  • Where possible, residents should be involved in decisions about taking PRN medication.
  • If a resident lacks capacity, best interest decisions must be made in line with the Mental Capacity Act 2005.

5. Administration of PRN Medication

• Authorised Staff:
  • Only trained and authorised staff may administer PRN medication.
  • Staff must check the resident’s care plan and prescription details before administration.
• Checking Prior to Administration:
  • Ensure medication has not already been administered within the safe time limits.
  • Confirm symptoms match the prescribed indications.
• Recording Administration:
  • Document the date, time, dose, reason for administration, and staff signature in the Medication Administration Record (MAR) sheet.
  • Monitor and record the resident’s response to the medication.

6. Monitoring and Review of PRN Medication

• Effectiveness Review:
  • Staff must monitor and document the effectiveness of PRN medication after administration.
  • Any adverse effects must be reported immediately.
• Regular Medication Reviews:
  • PRN prescriptions are reviewed at least every six months by a GP or pharmacist.
  • If PRN medication is used frequently, alternative treatment options should be explored.

7. Storage and Security of PRN Medication

• Safe Storage:
  • PRN medication must be stored securely in a locked medication cupboard.
  • Temperature-sensitive PRN medication must be stored in a temperature-controlled environment.
• Stock Control:
  • Regular stock checks must be conducted to prevent overstocking or shortages.
  • Expiry dates must be monitored, and expired medication disposed of appropriately.

8. Handling Refusals of PRN Medication

• Resident Choice:
  • Residents have the right to refuse PRN medication unless it is legally required.
• Documentation of Refusals:
  • All refusals must be recorded in the MAR chart, including the reason for refusal if known.
• Staff Action:
  • If refusal may result in harm, staff should escalate concerns to a healthcare professional.

9. PRN Medication for Behavioural Support

• Non-Pharmacological Approaches First:
  • PRN medication should only be used for behavioural management when other de-escalation strategies have been attempted.
• Care Plan Guidelines:
  • Behavioural PRN medication must be included in a clear, structured care plan.
• Review and Reduction Strategies:
  • Regular review by healthcare professionals to prevent long-term reliance on PRN medication.

10. Staff Training and Competency

• Mandatory Training:
  • All staff responsible for administering PRN medication must complete annual medication training.
• Competency Assessments:
  • Staff undergo regular competency assessments to ensure safe administration practices.

11. Compliance and Auditing

• Regular Audits:
  • Monthly medication audits ensure PRN medication is used appropriately.
• CIW Compliance:
  • Compliance with CIW regulations is monitored through inspections and internal audits.
• Incident Reporting:
  • Any medication errors or concerns must be reported through the incident reporting system.

12. Related Policies

This policy should be read in conjunction with:

• CHW11 – Safe Care and Treatment Policy
• CHW21 – Medication Management and Administration Policy
• CHW13 – Safeguarding Adults from Abuse and Improper Treatment Policy
• CHW39 – Mental Capacity and Deprivation of Liberty Safeguards Policy

13. Policy Review

This policy will be reviewed annually or sooner if there are changes in legislation, regulatory requirements, or organisational needs. Any updates will be communicated to all staff through training sessions and policy briefings.

---

Responsible Person: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Reviewed on: {{last_update_date}}
Next Review Date: {{next_review_date}}
Copyright © {{current_year}} – {{org_field_name}}. All rights reserved.